Mycophenolate mofetil Enrolling by Invitation Phase 2 Trials for Sjögren's Syndrome Treatment

IndicationsStatusPurposePhase
Enrolling by InvitationTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02691949Efficacy and Safety of Mycophenolate Mofetil in subjectswithSjogren's Syndrome